Comparison of direct oral anticoagulants and vitamin K antagonists in the treatment of left ventricular thrombi: a retrospective cohort study
LVT treated solely with either DOACs or VKAs had similar incidences of SSE, LVT resolution, time to LVT resolution, and mortality. VKA therapy, however, was associated with a higher incidence of major bleeding events.
Authors
- Raymond C. Shields
- Damon E. Houghton (ORCID: https://orcid.org/0000-0002-6065-9523)
- Thom W. Rooke (ORCID: https://orcid.org/0000-0003-3089-3156)
- Kirsten Lipps (ORCID: https://orcid.org/0000-0001-8298-4776)
- Stanislav Henkin (ORCID: https://orcid.org/0000-0001-5968-1216)
- Samuel Heller
- Robert D. McBane (ORCID: https://orcid.org/0000-0001-8727-8029)
- Waldemar E. Wysokiński (ORCID: https://orcid.org/0000-0002-8119-6206)
- David Liedl (ORCID: https://orcid.org/0009-0008-4038-659X)
- Paul W. Wennberg (ORCID: https://orcid.org/0000-0002-5964-6637)
- Ana I. Casanegra (ORCID: https://orcid.org/0000-0001-6114-4284)
- Hossam Elbenawi
Institutions
- Mayo Clinic (US)
- Charles University (CZ)
Publication Details
- Journal
- Research and Practice in Thrombosis and Haemostasis
- Published
- 2025-09-25
- DOI
- https://doi.org/10.1016/j.rpth.2025.103192
- Citations
- 2
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 2.78